Learn more

NACUITY PHARMACEUTICALS INC

Overview
  • Total Patents
    31
  • GoodIP Patent Rank
    51,542
  • Filing trend
    ⇧ 1200.0%
About

NACUITY PHARMACEUTICALS INC has a total of 31 patent applications. It increased the IP activity by 1200.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machines are PALCZEWSKI KRZYSZTOF, GALAT ALEXANDER and RADOPATH LTD.

Patent filings per year

Chart showing NACUITY PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wall G Michael 15
#2 Tucker Rodney 8
#3 Rubenstein Anja 8
#4 Johnson Doug 8
#5 Bolger Josh 7
#6 Wall G 7
#7 Campochiaro Peter A 5
#8 Hartman Daniel 4
#9 Thota Sambaiah 3
#10 Cheruku Srinavasa 3

Latest patents

Publication Filing date Title
US2020277258A1 Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof
WO2020146666A1 N-acetylcysteine amide (naca) and (2r,2r')-3,3'-disulfanediyl bis (2-acetamidopropanamide) (dinaca) for the prevention and treatment of radiation dermatitis and skin lightening, skin whitening and skin improvement
US2020222344A1 Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide)(DiNACA)
WO2020146660A1 N-acetylcysteine amide (naca) and (2r,2r')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (dinaca) for prevention and treatment of radiation pneumonitis and treatment of pulmonary function in cystic fibrosis
US2020217852A1 Quantitation of Free and Total N-Acetylcysteine Amide and Its Metabolite N-Acetylcysteine in Human Plasma Using Derivatization and Electrospray LC-MS/MS
US2019135741A1 Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
WO2019060623A1 Method for preparation of n-acetyl cysteine amide and derivatives thereof
US2017183302A1 Method for preparation of N-acetyl cysteine amide